ABBV vs MTRN · P/E 81, rev $16.99B vs P/E 73, rev $1.16B
AbbVie Inc (ABBV) versus Materion Corporation (MTRN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Materion Corporation (MTRN) is a other industrial metals & mining company listed on NYSE.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported MTRN revenue for 2026-07-03 was $1.16B. Net income was $58.1M. MTRN currently screens at market cap $5.49B and trailing P/E 72.5.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. MTRN currently screens at market cap $5.49B and trailing P/E 72.5.
Not investment advice. Open the ABBV and MTRN stock pages for the full models.
Not investment advice.